Printer Friendly

Wilex secures EUR9.93m from cap increase.

M2 PHARMA-February 1, 2012-Wilex secures EUR9.93m from cap increase(C)2012 M2 COMMUNICATIONS

1 February 2012 - German biopharmaceutical company Wilex AG (ETR:WL6) said on Wednesday it had secured gross proceeds of EUR9.93m (USD13.1m) from the implementation of a capital hike.

The company will use the finding to finance ongoing clinical trials as well as to strengthen its capital base.

Wilex issued a total of 3.2m new shares at a subscription price of EUR3.10 apiece and a subscription ratio of 27:4.

The company has thus raised its share capital to EUR24.8m from the prior EUR21.6m.

(EUR1 = USD1.317)

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2012 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2012 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Date:Feb 1, 2012
Words:117
Previous Article:Glaxo, Lilly, Pfizer join race for MN Pharmaceuticals.
Next Article:Roche boosts 2011 net profit by 8% Y/Y.

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters